/People

Jim Robinson

Investor

Senior Advisor at Adjuvant Capital

Find your path to Jim

Sign up to see every warm intro you have to Jim

  • Paths you didn't know you had: your email and LinkedIn already hold routes to Jim. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

About

Jim Robinson is a biologics manufacturing expert who served as Vice President, Global Technical Operations, Vaccines, Biological and Sterile Products at Merck & Co. from 2010 to 2015, and earlier as Vice President, Technical and Quality Operations at Novavax from 2007 to 2010. He previously spent about 20 years at Sanofi Pasteur, including as Vice President, Industrial Operations from 1998 to 2006. He holds Master's and Bachelor's degrees in Chemical Engineering from Lehigh University and serves on several scientific advisory boards, including as Vice Chair of CEPI's Scientific Advisory Committee.

Invests in

Biotech

Colleagues at Adjuvant Capital

Frequently asked questions

Who is Jim Robinson?
Jim Robinson is a biologics manufacturing expert who served as Vice President, Global Technical Operations, Vaccines, Biological and Sterile Products at Merck & Co. from 2010 to 2015, and earlier as Vice President, Technical and Quality Operations at Novavax from 2007 to 2010. He previously spent about 20 years at Sanofi Pasteur, including as Vice President, Industrial Operations from 1998 to 2006. He holds Master's and Bachelor's degrees in Chemical Engineering from Lehigh University and serves on several scientific advisory boards, including as Vice Chair of CEPI's Scientific Advisory Committee.
Where does Jim Robinson work?
Jim Robinson is Senior Advisor at Adjuvant Capital.
What does Jim Robinson invest in?
Jim Robinson invests in Biotech.

About this profile. Compiled from public sources — Adjuvant Capital's own website and public professional profiles — and summarised by Fundraising Fox; every fact is kept with where it came from. Spotted an error, or would rather not be listed? Email privacy@fundraisingfox.com · How we build profiles · Your rights